Review: taking Coumadin and Voltaren together


Summary

Drug interactions are reported among people who take Coumadin and Voltaren together. This review analyzes the effectiveness and drug interactions between Coumadin and Voltaren. It is created by eHealthMe based on reports of 1,011 people who take the same drugs from FDA and social media, and is updated regularly.

You are not alone

Join a support group for people who take Coumadin and Voltaren >>>

Personalized health information

On eHealthMe you can find out what patients like me (same gender, age) reported their drugs and conditions on FDA and social media since 1977. Our tools are free and anonymous. 86 million people have used us. 300+ peer-reviewed medical journals have referenced our original studies. Start now >>>


Coumadin

Coumadin has active ingredients of warfarin sodium. It is often used in atrial fibrillation/flutter. (latest outcomes from Coumadin 80,735 users)

Voltaren

Voltaren has active ingredients of diclofenac sodium. It is often used in rheumatoid arthritis. (latest outcomes from Voltaren 21,795 users)

On Aug, 22, 2016

1,011 people who take Coumadin, Voltaren are studied.


Number of reports submitted per year:

Coumadin and Voltaren drug interactions.

Drug effectiveness over time:

Coumadin:
  • < 1 month: 0.0% - (0 of 1 people)
  • 1 - 6 months: 100.0% - (1 of 1 people)
  • 6 - 12 months: 0.0% - (0 of 0 people)
  • 1 - 2 years: 100.0% - (1 of 1 people)
  • 2 - 5 years: 50.0% - (1 of 2 people)
  • 5 - 10 years: 100.0% - (2 of 2 people)
  • 10+ years: 0.0% - (0 of 0 people)
  • not specified: 0.0% - (0 of 0 people)
Voltaren:
  • < 1 month: 33.0% - (1 of 3 people)
  • 1 - 6 months: 0.0% - (0 of 0 people)
  • 6 - 12 months: 0.0% - (0 of 1 people)
  • 1 - 2 years: 100.0% - (2 of 2 people)
  • 2 - 5 years: 50.0% - (1 of 2 people)
  • 5 - 10 years: 100.0% - (1 of 1 people)
  • 10+ years: 0.0% - (0 of 1 people)
  • not specified: 0.0% - (0 of 0 people)

Drug effectiveness by gender:

Coumadin:
  • female: 60.0% - (3 of 5 people)
  • male: 100.0% - (2 of 2 people)
Voltaren:
  • female: 50.0% - (3 of 6 people)
  • male: 50.0% - (2 of 4 people)

Drug effectiveness by age:

Coumadin:
  • 0-1: 0.0% - (0 of 0 people)
  • 2-9: 0.0% - (0 of 0 people)
  • 10-19: 0.0% - (0 of 0 people)
  • 20-29: 0.0% - (0 of 0 people)
  • 30-39: 0.0% - (0 of 0 people)
  • 40-49: 100.0% - (1 of 1 people)
  • 50-59: 100.0% - (1 of 1 people)
  • 60+: 60.0% - (3 of 5 people)
Voltaren:
  • 0-1: 0.0% - (0 of 0 people)
  • 2-9: 0.0% - (0 of 0 people)
  • 10-19: 0.0% - (0 of 0 people)
  • 20-29: 0.0% - (0 of 0 people)
  • 30-39: 0.0% - (0 of 0 people)
  • 40-49: 100.0% - (2 of 2 people)
  • 50-59: 0.0% - (0 of 1 people)
  • 60+: 42.0% - (3 of 7 people)

Most common drug interactions over time *:

< 1 month:
  • fall
  • international normalised ratio increased
  • rash
  • cerebral infarction
  • dehydration
  • disseminated intravascular coagulation
  • hyperkalaemia
  • toxic epidermal necrolysis
  • blister
  • blood pressure decreased
1 - 6 months:
  • anaemia
  • international normalised ratio increased
  • epistaxis
  • gastrointestinal haemorrhage
  • overdose
  • psoriatic arthropathy
  • bronchopneumonia
  • cardiopulmonary failure
  • interstitial lung disease
  • loss of consciousness
6 - 12 months:
  • deep vein thrombosis
  • emotional distress
  • injury
  • pain
  • international normalised ratio increased
  • arthralgia
  • atrial fibrillation
  • diabetes mellitus
  • epistaxis
  • feeling abnormal
1 - 2 years:
  • brain injury
  • cerebral thrombosis
  • cerebral venous thrombosis
  • headache
  • haematemesis
  • anaemia
  • brain neoplasm
  • complication of pregnancy
  • confusional state
  • gastric ulcer
2 - 5 years:
  • gastroduodenal ulcer
  • melaena
  • gastric ulcer haemorrhage
  • large intestinal haemorrhage
  • coagulopathy
  • colitis
  • dyschezia
  • haematemesis
  • haemorrhage subcutaneous
  • injection site haemorrhage
5 - 10 years:
  • anaemia
  • melaena
  • syncope
  • epistaxis
  • eyelid ptosis
  • gastric ulcer
  • haematemesis
  • migraine with aura
  • overdose
  • pupils unequal
10+ years:
  • international normalised ratio increased
  • melaena
  • abdominal pain
  • blood pressure fluctuation
  • cold sweat
  • gastric ulcer
  • general physical health deterioration
  • haemoglobin decreased
  • haemorrhagic anaemia
  • haemorrhagic diathesis
not specified:
  • pain
  • anaemia
  • fall
  • anxiety
  • dyspnoea
  • injury
  • diarrhoea
  • international normalised ratio increased
  • back pain
  • vomiting

Most common drug interactions by gender *:

female:
  • fall
  • nausea
  • vomiting
  • pain
  • anaemia
  • dehydration
  • arthralgia
  • international normalised ratio increased
  • pyrexia
  • atrial fibrillation
male:
  • anaemia
  • pain
  • back pain
  • injury
  • chest pain
  • dyspnoea
  • anxiety
  • osteonecrosis of jaw
  • diarrhoea
  • oedema peripheral

Most common drug interactions by age *:

10-19:
  • anxiety
  • arteritis
  • blindness
  • cellulitis
  • colitis ulcerative
  • confusional state
  • conversion disorder
  • dermal cyst
  • diarrhoea
  • drug ineffective
20-29:
  • pulmonary embolism
  • arthralgia
  • injury
  • diabetes mellitus
  • migraine
  • upper respiratory tract inflammation
  • anxiety
  • cerebrovascular accident
  • fear
  • pain
30-39:
  • headache
  • deep vein thrombosis
  • limb discomfort
  • migraine
  • oedema peripheral
  • pain in extremity
  • vomiting
  • brain injury
  • cerebral thrombosis
  • cerebral venous thrombosis
40-49:
  • ecchymosis
  • hypovolaemic shock
  • arthralgia
  • extradural haematoma
  • melaena
  • back pain
  • paraparesis
  • loss of bladder sensation
  • myalgia
  • purpura
50-59:
  • anxiety
  • pain
  • osteonecrosis of jaw
  • anaemia
  • bone disorder
  • chest pain
  • injury
  • swelling face
  • diarrhoea
  • cellulitis
60+:
  • fall
  • international normalised ratio increased
  • anaemia
  • haemoglobin decreased
  • nausea
  • atrial fibrillation
  • fatigue
  • pain
  • renal failure acute
  • vomiting

* Approximation only. Some reports may have incomplete information.

How to use the study: print a copy of the study and bring it to your health teams to ensure drug risks and benefits are fully discussed and understood.

Do you take Coumadin and Voltaren?

Can you answer these questions?

More questions for: Coumadin, Voltaren

You may be interested in these reviews

More reviews for: Coumadin, Voltaren

On eHealthMe, Coumadin (warfarin sodium) is often used to treat atrial fibrillation/flutter. Voltaren (diclofenac sodium) is often used to treat rheumatoid arthritis. Find out below the conditions the drugs are used for and how effective they are.

What is the drug used for and how effecitve is it:


NOTE: The study is based on active ingredients and brand name. Other drugs that have the same active ingredients (e.g. generic drugs) are NOT considered.

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only, and has not been supported by scientific studies or clinical trials unless otherwise stated. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

You may report adverse side effects to the FDA at http://www.fda.gov/medwatch/ or 1-800-FDA-1088 (1-800-332-1088).

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.